Antony W. Braithwaite
Auckland, AUK 1142, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
YBX1 Expression Marks Proliferative Tumour States with Context-Dependent Genomic Instability: A Pan-Cancer Analysis.
Journal: International journal of molecular sciences
Published: March 19, 2026
TP53 Splice Mutations Have Tumour-Independent Effects on Genomic Stability and Prognosis: An In Silico Study.
Journal: International journal of molecular sciences
Published: November 11, 2025
TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.
Journal: Cancer gene therapy
Published: July 30, 2025
Δ133p53 isoform enhances TLR4 function to promote tumor growth.
Journal: Carcinogenesis
Published: February 22, 2025
Immune Checkpoint Inhibitor Therapy for Metastatic Melanoma: What Should We Focus on to Improve the Clinical Outcomes?
Journal: International journal of molecular sciences
Published: June 05, 2024
Combining TP53 mutation and isoform has the potential to improve clinical practice.
Journal: Pathology
Published: October 02, 2023
Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: November 11, 2022
Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis.
Journal: International journal of molecular sciences
Published: November 10, 2022
Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage.
Journal: Cell death & disease
Published: March 23, 2022
Importance of crosstalk between the microbiota and the neuroimmune system for tissue homeostasis.
Journal: Clinical & translational immunology
Published: December 22, 2021
Effect of p53 and its N-terminally truncated isoform, Δ40p53, on breast cancer migration and invasion.
Journal: Molecular oncology
Published: July 15, 2021
Last Updated: 09/26/2026